Urological surgery
Conditions
Interventions
Experimental group:the endoscopic surgical system for urological surgery
Sponsors
Shanghai Changhai Hospital
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. The age is not less than 18 years old, and the gender is not limited; 2. Those who need to receive urological surgery; 3. Body mass index (BMI): 18.5 ~ 30 kg/m2; 4. Patients whose physical status is graded from grade i to grade iii, according to the classification system of the American Association of Anesthesiologists (ASA) ; 5. Those who are able to cooperate in completing the visits and related inspections specified in the plan; 6. The subject voluntarily participates in the clinical trial, and agrees or is agreed by the guardian to sign an informed consent form.
Exclusion criteria
Exclusion criteria: 1. Those who have other malignant tumors or have a history of other malignant tumors in the past; 2. Patients who have received surgical treatment of the urinary system in the past; 3. Those who have undergone other major surgery within 3 months before the enrollment and during the trial period, or who cannot recover from the side effects of any such surgery; 4. Patients with active tuberculosis; 5. Immunodeficiency virus (HIV) antibody positive; hepatitis B surface antigen (HbsAg) or hepatitis B core antibody (HbcAb) positive, and the copy number of hepatitis B virus DNA (HBV-DNA) is higher than the lower limit of detection or the normal range patients; Hepatitis C virus (HCV) antibody positive patients; Treponema pallidum positive patients; 6. Those who suffer from serious systemic diseases and are deemed unsuitable for surgical treatment by the investigator; 7. Long-term user of anticoagulant and antiplatelet drugs (anti-platelet aggregation drugs are discontinued less than 1 week before surgery), or patients with a history of bleeding disorders or hematopoietic dysfunction or coagulation dysfunction; 8. People with severe allergies and suspected or determined addiction to alcohol, medicines or drugs; 9. Those with a history of epilepsy or mental illness or cognitive impairment; 10. Women who are pregnant, breastfeeding or planning to become pregnant during the trial, and men or women who are unwilling to take barrier contraceptive measures during the trial; 11. Those who have participated in other interventional clinical trials within 3 months before screening; 12. Other situations where the investigator thinks it is inappropriate to participate in this trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Surgical success rate; | — |
Countries
China
Contacts
Public ContactWang Linhui
Shanghai Changhai Hospital
Outcome results
None listed